ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,473 | +49.5% | 19,705 | +98.4% | 0.01% | +20.0% |
| Q2 2023 | $354,175 | +9.0% | 9,932 | +7.7% | 0.01% | -16.7% |
| Q2 2022 | $325,000 | -19.6% | 9,218 | +51.4% | 0.01% | +100.0% |
| Q4 2021 | $404,000 | +56.0% | 6,090 | +94.6% | 0.00% | +50.0% |
| Q2 2021 | $259,000 | -42.3% | 3,130 | -80.3% | 0.00% | -83.3% |
| Q3 2019 | $449,000 | +21.0% | 15,927 | -17.7% | 0.01% | -7.7% |
| Q3 2018 | $371,000 | +49.6% | 19,354 | -43.8% | 0.01% | -27.8% |
| Q1 2018 | $248,000 | – | 34,422 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |